D. Douglas
Primary
Amend KRS 15.291, 217.177, and 217.186 to define "opioid antagonist" as naloxone or any United States Food and Drug Administration-approved opioid antagonist designed to reverse the effects of an opioid overdose; replace references to naloxone with opiod antagonist.
signed by Governor (Acts Ch. 154)
delivered to Governor
posted for passage in the Consent Orders of the Day for Wednesday, March 30, 2022
3rd reading, passed 98-0
received in Senate
enrolled, signed by Speaker of the House
enrolled, signed by President of the Senate
taken from the Orders of the Day
returned to Rules
posted for passage in the Regular Orders of the Day for Wednesday, March 23, 2022
2nd reading, to Rules
reported favorably, 1st reading, to Calendar
to Health & Family Services (H)
received in House
to Committee on Committees (H)
3rd reading, passed 35-0 with Floor Amendment (1)
passed over and retained in the Orders of the Day
floor amendment (1) filed
2nd reading, to Rules
posted for passage in the Regular Orders of the Day for Tuesday, January 18, 2022
reported favorably, 1st reading, to Calendar
to Health & Welfare (S)
introduced in Senate
to Committee on Committees (S)
| Bill Text Versions | Format |
|---|---|
| Acts Chapter 154 | |
| Current/Final | |
| Introduced |
| Document | Format |
|---|---|
| Proposed Senate Floor Amendment 1 |
Data on Open States is updated periodically throughout the day from the official website of the Kentucky General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.